Pathophysiology of the MELAS 3243 transition mutation.

Flierl, A; Reichmann, H; Seibel, P

Flierl, A; Reichmann, H; Seibel, P.

Affiliation

Flierl A; Wissenschaftliche Nachwuchsgruppe, Theodor Boveri Institut, Biozentrum der Bayerischen-Julius-Maximillians-Universität, Am Hubland, 97074 Würzburg, Federal Republic of Germany.

J Biol Chem ; 272(43): 27189-96, 1997 Oct 24.

Article in En | MEDLINE | ID: mdl-9341162

Subject(s)

DNA, Mitochondrial/genetics; MELAS Syndrome/genetics; MELAS Syndrome/physiopathology; Mitochondria/enzymology; Mutation; B-Lymphocytes; Base Sequence; Cell Line, Transformed; Citrate (si)-Synthase/metabolism; DNA Primers; Electron Transport Complex IV/genetics; Electron Transport Complex IV/metabolism; Herpesvirus 4, Human; Humans; Kinetics; MELAS Syndrome/enzymology; Macromolecular Substances; NADH Dehydrogenase/metabolism; Oxidative Phosphorylation; Polymerase Chain Reaction; Protein Biosynthesis; RNA, Transfer, Leu/genetics; Reference Values; Succinate Cytochrome c Oxidoreductase/metabolism; Succinate Dehydrogenase/metabolism

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: DNA, Mitochondrial / MELAS Syndrome / Mitochondria / Mutation Limits: Humans Language: En Journal: J Biol Chem Year: 1997 Document type: Article Country of publication: United States

Search on Google

Add to My VHL

XML

PubMed Links